CG Oncology, Inc. Quarterly Operating Income (Loss) in USD from Q1 2023 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: CG Oncology, Inc. quarterly Operating Income (Loss) history and growth rate from Q1 2023 to Q3 2024.
CG Oncology, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$28.3M, a 101% decline year-over-year.

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024		-$28.3M	-$14.3M	-101%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-12
Q2 2024		-$25.9M	-$13.5M	-110%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024		-$22.5M	-$12.7M	-131%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q3 2023		-$14M			Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-12
Q2 2023		-$12.3M			Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023		-$9.72M			Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09

* An asterisk sign (*) next to the value indicates that the value is likely invalid.